Dynamic monitoring risk of anti-hepatoma new drug development / 中国中药杂志
China Journal of Chinese Materia Medica
;
(24): 4050-4053, 2014.
Artículo
en Chino
| WPRIM
| ID: wpr-310943
ABSTRACT
Risk monitoring of new Chinese patent anti-hepatoma drugs is tracking recognized risks and residual risks, identifying emerging risk and ensure the implementation of the plan, estimating the process of reducing effectiveness. The paper is mainly through understanding the status of Chinese patent anti-hepatoma drugs, the content, characteristic and analysis method of dynamic risk monitoring, and then select the risk control indicators, collect risk information. Finally, puts forward the thought of anti-hepatoma drugs listed evaluation in our country, and try to establish the model of dynamic risk management of anti-hepatoma drugs.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Vigilancia de Productos Comercializados
/
Medicamentos Herbarios Chinos
/
Carcinoma Hepatocelular
/
Usos Terapéuticos
/
Control de Medicamentos y Narcóticos
/
Quimioterapia
/
Economía
/
Descubrimiento de Drogas
/
Neoplasias Hepáticas
/
Antineoplásicos Fitogénicos
Tipo de estudio:
Estudio de etiología
/
Evaluación Económica en Salud
/
Estudio pronóstico
Límite:
Humanos
Idioma:
Chino
Revista:
China Journal of Chinese Materia Medica
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS